Business Context and Reporting Period
This Form 6-K filing is submitted by Midatech Pharma PLC (noted as Biodexa Pharmaceuticals Plc in request metadata) for the month of April 2018. The filing, dated April 9, 2018, incorporates by reference a press release titled "Notice of Preliminary Results." The registrant is a foreign private issuer based in Abingdon, Oxfordshire, United Kingdom, and files annual reports under Form 20-F.
Key Financial Metrics
The provided filing text serves as a cover sheet and exhibit index. It does not contain specific financial data regarding revenue, profit, cash flow, margins, debt, or liquidity. These metrics are presumably detailed in the attached Exhibit 99.1 (Press Release), the content of which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus prior periods. It only indicates that preliminary results for the period are available in the attached press release.
Guidance, Outlook, and Risks
No specific guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the provided text. The document solely references the existence of the "Notice of Preliminary Results" press release.
Investor Verification Checklist
- Verify the discrepancy between the request metadata ("Biodexa Pharmaceuticals Plc") and the filing registrant ("Midatech Pharma PLC").
- Locate and review the full text of Exhibit 99.1 ("Notice of Preliminary Results") to obtain actual financial figures.
- Confirm the specific reporting period covered by the preliminary results referenced in the press release.
- Check for any subsequent filings or updates regarding the company's financial status post-April 2018.